Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C

This study aims to develop a new self-report tool (HCV-AD) measuring adherence factors, intentional or unintentional, during Hepatitis C Virus (HCV) treatment with direct-acting antivirals (DAA) aiming to achieve high efficacy, otherwise resulting in drug resistance and treatment failure. Two phases...

Descripción completa

Detalles Bibliográficos
Autores principales: Turcu-Stiolica, Adina, Doica, Irina Paula, Ungureanu, Bogdan Silviu, Rogoveanu, Ion, Florescu, Dan Nicolae, Subtirelu, Mihaela-Simona, Gheonea, Dan Ionut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540644/
https://www.ncbi.nlm.nih.gov/pubmed/34683976
http://dx.doi.org/10.3390/pharmaceutics13101683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540644/
https://www.ncbi.nlm.nih.gov/pubmed/34683976
http://dx.doi.org/10.3390/pharmaceutics13101683

Ejemplares similares